HNRNPK and malignant colon neoplasm: The levels of lncRNA MYU, a downstream target of c-Myc, are increased in most colon cancers and enhance the G1-S transition in the cell cycle process via its interaction with hnRNP-K and subsequent stabilization of CDK6 in colon cancer cells.